The Truth About Prostate Health And Prostate Cancer

By age 30, 10% of men have benign prostatic hyperplasia (BPH), by age 60, 50%, by age 80, 90% causing symptoms and cancer risk. One in six develop prostate cancer. Those with prostate cancer today live no longer than those who had it in 1920. Treatments produce the same length of life, but when you modify your lifestyle, you may live longer. Dr. Simone reviews how prostate health can be yours. Since genetics cause only 7% of cases, you have control. Dr. Simone, a world renowned cancer specialist, is brave enough to share with you the truth about BPH and prostate cancer without emotion or influence from the medical establishment, pharmaceutical industry, national organizations, special interest groups or government agencies. Be your own advocate. Don't leave it to others. You can virtually control the destiny of your health. By following this easy Ten Point Plan, you can minimize BPH, reduce the risk for prostate cancer, or, if you have prostate cancer, you can help extend your life. The choice is yours.

Prostate cancer is unusual among solid tumors in that the majority of affected men die with, rather than of, the disease. This presents many challenges to healthcare professionals and patients in terms of deciding if, when and how to intervene in order to control tumor growth and spread, thereby extending survival but without compromising quality of life. This is the ninth edition of 'Fast Facts: Prostate Cancer' since 1996, testament to the rapid changes in the field and the steadily improving outlook for patients. This new edition provides many key updates: • the Gleason grade grouping, which has valuable prognostic value • nomograms to evaluate risk • our rapidly expanding understanding of the genetics and underlying pathogenesis of prostate cancer and the development of genomic tests to help identify those at greatest risk of developing clinically significant disease • the continuing debate about the role of PSA in the screening, detection and monitoring of prostate cancer • advances in imaging techniques, particularly multiparametric MRI, which is improving the accuracy of biopsy and reducing the numbers of negative biopsies • the roles of drugs, surgery and radiotherapy in the treatment of prostate cancer at different stages, and our ever-improving understanding of when and how best to intervene, aided by improving understanding of the risk factors for disease progression. Primarily intended for primary care providers, specialist nurses, junior doctors and allied healthcare professionals, this highly readable resource provides a comprehensive overview of prostate cancer, enabling fully informed discussions with patients about this complex disease. Contents: • Epidemiology and pathophysiology • Diet, lifestyle and chemoprevention • Screening and early detection • Diagnosis, staging and prognostic indicators • Management of clinically localized disease • Managing recurrence after initial therapy • Management of metastatic prostate cancer • Management of castrate-resistant prostate cancer • Survivorship and treatment complications

What foods should you eat if you want to keep your prostate healthy? How does sexual activity affect the health of your prostate? What are ways you can prevent prostate cancer? What should African-American men know about prostate cancer? What are the best alternatives to radiation and surgery in treating prostate cancer? What are the symptoms of an unhealthy prostate? These are some of the many important questions that are answered by Dr. Daniel W. Nixon, one of America's premier cancer research institute leaders, and Dr. Max Gomez, the charismatic health commentator whose reports are aired on NBC television stations nationwide. The authors not only provide indispensable guidance in cancer prevention but also offer a dynamic, new noninvasive treatment of prostate cancer. Packed with information, The Prostate Health Program explains in clear, simple language the link between obesity and prostate cancer, the difference between an enlarged prostate and a diseased one, the causes of frequent urination and pain, and the specific prostate problems pertaining to gay men. Drs. Nixon and Gomez offer a user-friendly plan of diet, exercise, and behavioral change that men can easily incorporate into their lives. The authors explain why aggressive treatment, such as radiation and surgery, is often unnecessary, less effective, and more dangerous -- often leaving men incontinent and impotent -- than other treatments. The cornerstones of this unique program are the Prostate Health Pyramid and the Transition Diet, both of which were created specifically for this book and are the ultimate tools in prostate cancer prevention, control, and treatment. First, the foods that protect the health of the prostate are identified; then, food changes are introduced slowly for more effective and long-lasting reform of eating habits. Best of all, quick and easy recipes created by chefs at the Culinary Institute of America provide a menu that is healthy and delicious. With its combination of cutting-edge research and highly respected, world-renowned authors, The Prostate Health Program is the definitive defense against a deadly disease.

Presents the latest recommendations on how to prevent or correctly diagnose problems, as well as the pros and cons of various mainstream and alternative medicine treatment options.

Every year, more than a million men undergo painful needle biopsies for prostate cancer, and upward of 100,000 have radical prostatectomies, resulting in incontinence and impotence. But the shocking fact is that most of these men would never have died from this common form of cancer, which frequently grows so slowly that it never even leaves the prostate. How did we get to a point where so many unnecessary tests and surgeries are being done? In The Great Prostate Hoax, Richard J. Ablin exposes how a discovery he made in 1970, the prostate-specific antigen (PSA), was co-opted by the pharmaceutical industry into a multibillion-dollar business. He shows how his discovery of PSA was never meant to be used for screening prostate cancer, and yet nonetheless the test was patented and eventurally approved by the FDA in 1994. Now, doctors and victims are beginning to speak out about the harm of the test, and beginning to search for a true prostate cancer-specific marker.

Prostate cancer is the second most common cancer in men worldwide, but it is unusual among solid tumors in that many men die with, rather than of, the disease. This raises challenges in terms of deciding if, when, and how to intervene to control tumor growth and spread in order to extend survival without compromising quality of life. The many developments in the field since the last edition of this book include continuing studies to improve detection and monitoring of the disease, with the evaluation of MRI for screening and prostate-specific membrane antigen (PSMA)-PET/CT for staging. Treatment options have also continued to improve and expand for all stages of the disease with the development of ultrahypofractionated radiotherapy, oral LHRH antagonists, PARP inhibitors and lutetium-177 PSMA-617 radioligand therapy.